Lilly strikes a manufacturing deal to supply insulin in Africa; AbbVie exits major pharma lobbying groups

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by       STAT+: Amid criticism over unaffordable insulin, Lilly strikes a manufacturing deal to supply Africa By Ed Silverman NASA Lilly agreed to sell active pharmaceutical ingredients at reduced prices and transfer technology to an Egyptian company. Read More STAT+: AbbVie exits major pharmaceutical industry lobbying groups By Rachel Cohrs and Sarah Owermohle Ruby Wallau for STAT The maker of one of the world’s most profitable medicines is exiting the pharma industry’s two major lobbying organizations next year. Read More STAT+: Inflation caused another big drop in net drug prices, analysis finds By Ed Silverman Adobe Drugmakers raised wholesale prices by 4.8% in the third quarter this year, but when accounting for inflation, wholesale prices fell by 3.1%. Read More Sponsored Insight by PHARMACYCLICS & JANSSEN ONCOLOGY 'No one will advocate for me better than myself': Hannah's story of living with CLL Hannah was leading an active lifestyle as a full-time employee, foster parent of six, wife and enthusiastic crafter when she received her diagnosis of chronic lymphocytic leukemia (CLL), an incurable form of blood cancer. After about a year of treatment, it became clear Hannah needed a second opinion to get back to her lifestyle. Read more about Hannah's journey and why she chose to advocate for herself. Watch: With little more than a typewriter, an Idaho man overturns the entire state's policy on hepatitis C treatment in prison By Nicholas Florko Alex Hogan/STAT Writing his lawsuit on a typewriter, Phil Turney eventually overturned Idaho's policy on hepatitis C treatment for incarcerated people. Read More Listen: Leaky health data, ASH22, & what it takes to get booed by your peers By Damian Garde and Allison DeAngelis and Adam Feuerstein STAT's Katie Palmer joins us to explain how telehealth is putting sensitive patient information into the hands of big tech firms. Read More Thursday, December 15, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser